<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> is an inherited <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disorder</z:e> with an autosomic dominant transmission </plain></SENT>
<SENT sid="1" pm="."><plain>The prevalence is 1:5000-10 000 and the clinical major criteria involve the skeletal and ocular apparatus and the cardiovascular and central <z:mp ids='MP_0008912'>nervous</z:mp> system </plain></SENT>
<SENT sid="2" pm="."><plain>The main cause of morbidity is represented by the thoracic <z:hpo ids='HP_0002647'>aortic dissection</z:hpo>/<z:hpo ids='HP_0002617'>aneurysm</z:hpo> that is responsible for 80% of the <z:hpo ids='HP_0011420'>deaths</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: We performed a clinical study on 227 patients enrolled at our Clinical and Research Marfan and Related Disorders Center </plain></SENT>
<SENT sid="4" pm="."><plain>The aim of this study was to describe the prevalence of cardiovascular manifestation in this cohort of patients </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: <z:mp ids='MP_0010574'>Aortic dilation</z:mp> was present in 172 patients (75.8%), <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> in 179 (78.9%) </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001659'>Aortic insufficiency</z:hpo> was present in 83 patients (36.6%), <z:hpo ids='HP_0001653'>mitral insufficiency</z:hpo> in 165 (72.7%) </plain></SENT>
<SENT sid="7" pm="."><plain>When analyzed separately, in &lt; 10-year and &gt; 40-year patients <z:mp ids='MP_0010574'>aortic dilation</z:mp> was more prevalent than <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Three patients presented with <z:mp ids='MP_0010403'>interatrial septal defect</z:mp>, 4 aortic bicuspid valve; 23 had a history of ventricular and <z:hpo ids='HP_0005115'>supraventricular arrhythmias</z:hpo>, and in 2 patients an implantable cardioverter device had been implanted </plain></SENT>
<SENT sid="9" pm="."><plain>Fifty-seven patients were treated with beta-blockers and 28 had been operated for aortic aneurysmal dilation </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: In <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> <z:hpo ids='HP_0001634'>mitral valve prolapse</z:hpo> and <z:mp ids='MP_0010574'>aortic dilation</z:mp> are the main cardiovascular manifestations, <z:mp ids='MP_0010403'>interatrial septal defect</z:mp> and aortic bicuspid valve had the same prevalence than in subjects without <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>These data refer to our first patient evaluation; further studies are needed to evaluate the progression and the natural history of cardiovascular manifestations in <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
</text></document>